(Q38016072)

27 August 2017

title

Complement in the immunopathogenesis of rheumatic disease (English)

1 reference

27 August 2017

Gunnar Sturfelt

1

1 reference

27 August 2017

Lennart Truedsson

series ordinal

2

1 reference

27 August 2017

language of work or name

English

0 references

publication date

5 June 2012

1 reference

Nature Reviews Rheumatology

27 August 2017

published in

1 reference

27 August 2017

volume

8

1 reference

27 August 2017

issue

8

1 reference

27 August 2017

page(s)

458-468

1 reference

https://scigraph.springernature.com/pub.10.1038/nrrheum.2012.75

27 August 2017

exact match

0 references

cites work

Unique role of the complement receptor CR1 in the degradation of C3b associated with immune complexes

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2012.75

The CD19/CR2/TAPA-1 complex of B lymphocytes: linking natural to acquired immunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2012.75

Linkages of innate and adaptive immunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2012.75

Novel roles of complement in T effector cell regulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2012.75

Molecular organization and function of the complement system

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2012.75

Complement deficiency states and associated infections

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2012.75

Complement deficiencies and systemic lupus erythematosus

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2012.75

Association of mannose-binding lectin gene variation with disease severity and infections in a population-based cohort of systemic lupus erythematosus patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2012.75

Homozygous single nucleotide polymorphism of the complement C1QA gene is associated with decreased levels of C1q in patients with subacute cutaneous lupus erythematosus

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2012.75

Sex, MHC and complement C4 in autoimmune diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2012.75

The internal thioester and the covalent binding properties of the complement proteins C3 and C4

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2012.75

Immune complex processing in patients with systemic lupus erythematosus. In vivo imaging and clearance studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2012.75

Homozygous C1q deficiency causes glomerulonephritis associated with multiple apoptotic bodies

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2012.75

Complement classical pathway components are all important in clearance of apoptotic and secondary necrotic cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2012.75

Complement C1q regulates LPS-induced cytokine production in bone marrow-derived dendritic cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2012.75

Induction of interferon-alpha production in plasmacytoid dendritic cells by immune complexes containing nucleic acid released by necrotic or late apoptotic cells and lupus IgG.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2012.75

Update on complement in the pathogenesis of systemic lupus erythematosus

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2012.75

The role of antibodies and B cells in the pathogenesis of lupus nephritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2012.75

Lupus anti-DNA autoantibodies cross-react with a glomerular structural protein: a case for tissue injury by molecular mimicry

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2012.75

The prognosis and pathogenesis of severe lupus glomerulonephritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2012.75

Role of anti-C1q autoantibodies in the pathogenesis of lupus nephritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2012.75

Autoantibodies against complement C1q specifically target C1q bound on early apoptotic cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2012.75

Complement and renal disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2012.75

Impairment of neutrophil extracellular trap degradation is associated with lupus nephritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2012.75

Association of systemic lupus erythematosus with C8orf13-BLK and ITGAM-ITGAX

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2012.75

Neutrophils activate plasmacytoid dendritic cells by releasing self-DNA-peptide complexes in systemic lupus erythematosus

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2012.75

Complement-induced granulocyte aggregation: an unsuspected mechanism of disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2012.75

The contact/kinin and complement systems in vasculitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2012.75

Systemic lupus erythematosus serum deposits C4d on red blood cells, decreases red blood cell membrane deformability, and promotes nitric oxide production

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2012.75

Solid-phase classical complement activation by C-reactive protein (CRP) is inhibited by fluid-phase CRP-C1q interaction.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2012.75

Prevention and reversal of nephritis in MRL/lpr mice with a single injection of C-reactive protein.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2012.75

Lack of effect of a single injection of human C-reactive protein on murine lupus or nephrotoxic nephritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2012.75

Complement and the antiphospholipid syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2012.75

Complement C3 activation is required for antiphospholipid antibody-induced fetal loss

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2012.75

Rheumatological manifestations, organ damage and autoimmunity in hereditary C2 deficiency.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2012.75

Complement factor H deficiency accelerates development of lupus nephritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2012.75

Mutations in genes encoding complement inhibitors CD46 and CFH affect the age at nephritis onset in patients with systemic lupus erythematosus

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2012.75

Ultraviolet light-induced keratinocyte apoptosis: a potential mechanism for the induction of skin lesions and autoantibody production in LE.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2012.75

Development of lupus nephritis is associated with qualitative changes in the glomerular collagen IV matrix composition.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2012.75

Complement inhibitor C4b-binding protein in primary Sjögren's syndrome and its association with other disease markers.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2012.75

Pathogenic aspects of dermatomyositis, polymyositis and overlap myositis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2012.75

Comparative proteomic analysis of serum from patients with systemic sclerosis and sclerodermatous GVHD. Evidence of defective function of factor H

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2012.75

HEMOLYTIC COMPLEMENT IN SYNOVIAL FLUID.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2012.75

Rheumatoid arthritis and the complement system.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2012.75

A recombinant vaccine effectively induces c5a-specific neutralizing antibodies and prevents arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2012.75

Complement in acute and chronic arthritides: assessment of C3c, C9, and protectin (CD59) in synovial membrane

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2012.75

Role of C3a receptors, C5a receptors, and complement protein C6 deficiency in collagen antibody-induced arthritis in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2012.75

Cartilage specific collagen activates macrophages and the alternative pathway of complement: evidence for an immunopathogenic concept of rheumatoid arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2012.75

Mannan-binding lectin and its role in innate immunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2012.75

The extracellular matrix and inflammation: fibromodulin activates the classical pathway of complement by directly binding C1q.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2012.75

Regulation of complement by cartilage oligomeric matrix protein allows for a novel molecular diagnostic principle in rheumatoid arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2012.75

Vasculitis in rheumatoid arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2012.75

Clinical and serological features of severe vasculitis in rheumatoid arthritis: prognostic implications

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2012.75

Identification of a central role for complement in osteoarthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2012.75

Alternative complement pathway in the pathogenesis of disease mediated by anti-neutrophil cytoplasmic autoantibodies

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2012.75

C5a receptor mediates neutrophil activation and ANCA-induced glomerulonephritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2012.75

Direct immunofluorescence in Behçet's disease: a controlled study with 108 cases

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2012.75

Western blot analysis of human IgG reactive with the collagenous portion of C1q: evidence of distinct binding specificities

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2012.75

Therapeutic complement inhibition: new developments

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2012.75

SLE with C1q deficiency treated with fresh frozen plasma: a 10-year experience

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2012.75

Experimental models of vasculitis and glomerulonephritis induced by antineutrophil cytoplasmic autoantibodies

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2012.75

Complement C3d conjugation to anthrax protective antigen promotes a rapid, sustained, and protective antibody response

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2012.75

Clinical presentations and molecular basis of complement C1r deficiency in a male African-American patient with systemic lupus erythematosus.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2012.75

Properdin deficiency: molecular basis and disease association

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2012.75

Heterogeneity in the genetic basis of human complement C9 deficiency

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2012.75

Anti-cyclic citrullinated peptide antibodies from rheumatoid arthritis patients activate complement via both the classical and alternative pathways

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2012.75

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2012.75

Genetically determined mannan-binding lectin deficiency is of minor importance in determining susceptibility to severe infections and vascular organ damage in systemic lupus erythematosus

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2012.75

Homozygous C4A deficiency in systemic lupus erythematosus: analysis of patients from a defined population

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2012.75

C1q inhibits immune complex-induced interferon-alpha production in plasmacytoid dendritic cells: a novel link between C1q deficiency and systemic lupus erythematosus pathogenesis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2012.75

Critical comparative analyses of anti-alpha-actinin and glomerulus-bound antibodies in human and murine lupus nephritis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2012.75

Glomerular apoptotic nucleosomes are central target structures for nephritogenic antibodies in human SLE nephritis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2012.75

Complement Components, Complement Activation, and Acute Phase Response in Systemic Lupus Erythematosus

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2012.75

Significance of histologic patterns of glomerular injury upon long-term prognosis in severe lupus glomerulonephritis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2012.75

Evidence for the presence of autoantibodies to the collagen-like portion of C1q in systemic lupus erythematosus

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2012.75

Uncontrolled C3 activation causes membranoproliferative glomerulonephritis in mice deficient in complement factor H

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2012.75

Increased IgG on cell-derived plasma microparticles in systemic lupus erythematosus is associated with autoantibodies and complement activation

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2012.75

Viable neutrophils release mitochondrial DNA to form neutrophil extracellular traps

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2012.75

Reduction by cimetidine of serum parathyroid hormone levels in uremic patients

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2012.75

Neutrophil aggregation induced by sera from patients with active systemic lupus erythematosus

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2012.75

C5a is important in the tubulointerstitial component of experimental immune complex glomerulonephritis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2012.75

THE APPLICATION OF THE FLUORESCENT ANTIBODY TECHNIC TO THE INVESTIGATION OF LUPUS ERYTHEMATOSUS AND VARIOUS DERMATOSES

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2012.75

Clinical expression of systemic lupus erythematosus in patients with C4A deficiency

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2012.75

Complement components, C1 activation and disease activity in SLE

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2012.75

C1 activation, with C1q in excess of functional C1 in synovial fluid from patients with rheumatoid arthritis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2012.75

Cell-derived microparticles in synovial fluid from inflamed arthritic joints support coagulation exclusively via a factor VII-dependent mechanism

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2012.75

Human complement activation via the alternative pathway on porcine endothelium initiated by IgA antibodies

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2012.75

Complement inhibitor C4b-binding protein interacts directly with small glycoproteins of the extracellular matrix

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2012.75

Interactions of the extracellular matrix proteoglycans decorin and biglycan with C1q and collectins

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2012.75

Inhibition of complement factor C5 protects against anti-myeloperoxidase antibody-mediated glomerulonephritis in mice

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2012.75

Pathophysiology of urticarial vasculitis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2012.75

31 March 2020

Hereditary angio-oedema

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2012.75

Mannose-binding lectin (MBL) therapy in an MBL-deficient patient with severe cystic fibrosis lung disease

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2012.75

Soluble human complement receptor type 1: in vivo inhibitor of complement suppressing post-ischemic myocardial inflammation and necrosis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2012.75

Treatment of experimental arthritis by targeting synovial endothelium with a neutralizing recombinant antibody to C5

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2012.75

MS analysis of rheumatoid arthritic synovial tissue identifies specific citrullination sites on fibrinogen.

31 March 2020

1 reference

12 December 2020

Synovial fluid levels of complement SC5b-9 and fragment Bb are elevated in patients with rheumatoid arthritis

1 reference

12 December 2020

Kinetic analysis of immune complex solubilization: complement function in relation to disease activity in SLE

1 reference

12 December 2020

THE DEPRESSED SYNOVIAL COMPLEMENT ACTIVITY IN ADULT AND JUVENILE RHEUMATOID ARTHRITIS

1 reference

12 December 2020

Studies of the third component of complement in synovial fluid from arthritic patients. II. Conversion and its relation to total complement

1 reference

12 December 2020

Interaction of the terminal complement components C5b-9 with synovial fibroblasts: binding to the membrane surface leads to increased levels in collagenase-specific mRNA

1 reference

12 December 2020

Lupus erythematosus associated with genetically determined deficiency of the second component of the complement

1 reference

12 December 2020

C1q binds directly and specifically to surface blebs of apoptotic human keratinocytes: complement deficiency and systemic lupus erythematosus revisited

1 reference

12 December 2020

Complement activation, circulating C1q binding substances and inflammatory activity in rheumatoid arthritis: relations and changes on suppression of inflammation

1 reference

12 December 2020

Nonimmune activation of the classical complement pathway.

1 reference

12 December 2020

Serial analysis of autoantibody responses to the collagen-like region of Clq, collagen type II, and double stranded DNA in patients with systemic lupus erythematosus

1 reference

12 December 2020

Successful plasma infusion treatment of a patient with C2 deficiency and systemic lupus erythematosus: clinical experience over forty-five months

1 reference

12 December 2020

The role of complement in B cell activation and tolerance.

1 reference

12 December 2020

Identifiers

DOI

10.1038/NRRHEUM.2012.75

1 reference

Dimensions Publication ID

27 August 2017

1023710686

0 references

1 reference